IKBKB and cerebellar ataxia: For this purpose, we inactivated IKK2-CA expression by administration of doxycycline in two experimental settings (Fig. 3a), either at the pre-symptomatic stage (8 weeks of age), or early after the onset of ataxia and inflammation, but before substantial Purkinje cell loss (12 weeks of age).